Our study made the cover of @CR_AACR! Congrats Faith Ryu (a talented ACRC @StanfordRadOnc heading to medical school next year) on this beautiful artwork showing the effect of #radiotherapy on #sarcoma evolution. A 🧵 of key findings from the most recent story from the lab. (1/8)
We are excited to announce that @everettmoding has been elected as the Councilor of Medicine for the @RRS_RadRes! In this role, Dr. Moding will help shape the direction of the radiation research community nationwide. Congratulations on this exceptional achievement!
Thank you @DeepaRangachari!! This would have not been possible without your help and amazing mentorship environment at @BIDMC_HOFellows! I'm honored to receive the support of @ConquerCancerFd as we strive to deliver new cell therapies to patients with solid tumors!
1/ Thrilled to share our new paper, out today in @Nature: "Non-invasive profiling of the tumour microenvironment with spatial ecotypes".
Paper (open access): https://t.co/EujZFqU7wi
Radiation is a powerful anti-cancer agent, but I considered it a weak immunomodulator. Our new study @CD_AACR changed my mind: in the right context, RT can incite potent systemic immune responses in patients (even rare irAEs). Which context? https://t.co/9zRrkQZGHD
A 🧵 /1
📢Yes, this is one of the best (or, just The Best) scientific meetings of the year: #RadRes2026 in beautiful Waikoloa Village #Hawaii
🔥Exciting scientific program - see link below🔥
➡️Registration is OPEN
➡️Abstracts open soon
Join us🤗
Preoperative therapy in high-risk UPS continues to challenge and inspire debate.
Join the experts for a deep dive into balancing radiation and systemic therapy in modern sarcoma care.
📅 Thursday, Nov 13, 2025
⏱️ 3:00–3:45 PM EST
Engage! Debate! Redefine the standard!
#CTOS2025
[1/10] We’re excited to introduce CytoTRACE 2 — a major upgrade for inferring developmental potential from single-cell RNA-seq across datasets. @naturemethods
Led by @kang_minji_ in @AaronNewmanLab.
📄 Paper: https://t.co/UgfI8tWeep
🔗 Shareable link: https://t.co/lzu5E2cYZF
🚨Our new paper is out today in Nature! We show that SARS-CoV-2 mRNA vaccines can sensitize tumors to immune checkpoint blockade (ICI) — revealing that clinically available RNA vaccines may act as potent immune modulators. https://t.co/sH13agsz5c
Looking forward to sharing our research on tumor heterogeneity tomorrow morning @WinshipAtEmory Grand Rounds and spending some time with the @EmoryRadOncRes residents!
#CTOS2025 Fall Webinar dedicated to the Sarcoma of the Year - Chondrosarcoma!
📆Friday, October 17th, 9.00 AM EST!
Excellent opportunity to broaden or refresh your knowledge on chondrosarcoma 🦴
Registration: https://t.co/H2CqvvH9EY
Thrilled our study exploring cell state ecosystems for NLPHL has been published. This represents a multi-year effort and the best collaborators in the world. Thread to follow. https://t.co/tp5jLUKC8l
@glow_nlphl@JamieFlerlage@AshAlizadeh@everettmoding@vit_prochazka
Grateful to be here in Peurto Rico for #RadRes2025!
I’m chairing 2 awesome sessions. One this morning & then belle of the ball tomorrow morning: “S29: Liquid biopsy technologies and biomarker discovery”.
@everettmoding, @PatelLabYale + my ⭐️ postdoc @MayoRadOnc Ayesha Hashmi!
We are excited to share that Jason Ross, MD, PhD, has received the Clin-STAR Aging Research Development and Training Award! These awards support various activities to help prepare early-career investigators for careers in aging-related research. Congratulations, Dr. Ross!